The primary breast cancer-related protein biomarkers for non-invasive clinical tests are the Human Epidermal growth factor Receptor 2 (HER2 or ErbB2), Carcinoembryonic Antigen (CEA), and Cancer Antigen 15–3 (CA15-3)13–15. This evidence concerns the gene CEACAM5 and breast cancer.